AGIOS PHARMACEUTICALS, INC. (AGIO) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00847X1046
AGIOS PHARMACEUTICALS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 54.03 m USD |
| Gross profit | 47.68 m USD |
| Operating income | -472.13 m USD |
| EBIT | -413.80 m USD |
| Net income | -412.78 m USD |
| Diluted EPS – continuing operations | -7.12 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AGIOS PHARMACEUTICALS, INC.
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
More stocks
- Youdao Inc (DAO)
- Shanghai Xinhua Media Co Ltd (600825.SS)
- Qingdao East Steel Tower Stock Co Ltd (002545.SZ)
- Zhongyuan Bank Co., Ltd. (ZNNGY)
- Epoxy Base Electronic Material Corp Ltd (603002.SS)
- PC CONNECTION INC (CNXN)
- BF SpA (BFG.MI)
- Top Choice Medical Investment Co Inc (600763.SS)
- Ovh Groupe SA (OVH.PA)
- TKH Group NV (TWEKA.AS)
- GCL Technology Holdings Ltd (3800.HK)
- BeiJing DaHao Technology Co Lt (603025.SS)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.